{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicxuxxk7xsarlmtxxyw2elsnxm67irqt3knpo4zx4jifp7jjfudxm",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mlcpamt2xhl2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/05/07/sanofi-diabetes-drug-voucher-fda-rethinking-rare-disease-rejection/?utm_campaign=rss",
  "publishedAt": "2026-05-07T13:47:21.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "Pharmalot",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "Sanofi asked the FDA to pull teplizumab out of a speedy review voucher program after a political appointee disagreed with staff over its approval",
  "title": "STAT+: Pharmalittle: We’re reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and more",
  "updatedAt": "2026-05-07T13:47:27.000Z"
}